Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech cash
Cash and short-term investments held at the end of each period.
Goldenwell Biotech's cash was $11.14K at Jun 30, 2026. For fiscal 2025 it was $26.78K, down 45.8% from the year before. The highest annual figure on record is $248.57K in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.78K | -45.8% |
| FY2024 | Dec 31, 2024 | $49.40K | -7.2% |
| FY2023 | Dec 31, 2023 | $53.23K | +15.7% |
| FY2022 | Dec 31, 2022 | $46.00K | -78.5% |
| FY2021 | Dec 31, 2021 | $213.56K | -14.1% |
| FY2020 | Dec 31, 2020 | $248.57K | +0.8% |
| FY2019 | Dec 31, 2019 | $246.59K | – |
| FY2018 | Dec 31, 2018 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.14K | -85.4% |
| Q1 FY2026 | Mar 31, 2026 | $13.41K | -21.7% |
| Q4 FY2025 | Dec 31, 2025 | $26.78K | -45.8% |
| Q3 FY2025 | Sep 30, 2025 | $45.62K | +859.5% |
| Q2 FY2025 | Jun 30, 2025 | $76.51K | +197.5% |
| Q1 FY2025 | Mar 31, 2025 | $17.13K | -29.3% |
| Q4 FY2024 | Dec 31, 2024 | $49.40K | -7.2% |
| Q3 FY2024 | Sep 30, 2024 | $4.76K | -60.1% |
| Q2 FY2024 | Jun 30, 2024 | $25.72K | +50.1% |
| Q1 FY2024 | Mar 31, 2024 | $24.22K | -45.0% |
| Q4 FY2023 | Dec 31, 2023 | $53.23K | +15.7% |
| Q3 FY2023 | Sep 30, 2023 | $11.92K | -79.5% |
| Q2 FY2023 | Jun 30, 2023 | $17.13K | -60.0% |
| Q1 FY2023 | Mar 31, 2023 | $44.08K | -79.4% |
| Q4 FY2022 | Dec 31, 2022 | $46.00K | -78.5% |
| Q3 FY2022 | Sep 30, 2022 | $58.09K | -75.1% |
| Q2 FY2022 | Jun 30, 2022 | $42.86K | -82.5% |
| Q1 FY2022 | Mar 31, 2022 | $213.56K | -14.1% |
| Q4 FY2021 | Dec 31, 2021 | $213.56K | -14.1% |
| Q3 FY2021 | Sep 30, 2021 | $232.93K | -7.0% |
| Q2 FY2021 | Jun 30, 2021 | $245.44K | -2.4% |
| Q1 FY2021 | Mar 31, 2021 | $248.57K | -1.2% |
| Q4 FY2020 | Dec 31, 2020 | $248.57K | +0.8% |
| Q3 FY2020 | Sep 30, 2020 | $250.54K | – |
| Q2 FY2020 | Jun 30, 2020 | $251.42K | – |
| Q1 FY2020 | Mar 31, 2020 | $251.56K | – |
| Q4 FY2019 | Dec 31, 2019 | $246.59K | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
See a number that looks wrong?